01. tbl. 101. árg. 2015
Review on coronary artery disease - Part II: Medical treatment, percutaneous interventions and myocardial revascularization
This article is the second of two review articles on coronary artery disease. The focus is on treatment with coverage of medical treatment, intravascular interventions and surgical therapy. The review is aimed at a wide readership of physicians and other health care providers but also at students of various health sciences. Current literature is reviewed with special focus on recent Icelandic studies.
Table I. Therapeutic agents used in the treatment of coronary artery diseae.
Antianginal agents
Nitrates
β-blockers
Calcium blockers
New agents (ivabradine, nicorandil, trimetazidine)
Agents used to reverse or slow progression of atherosclerosis
Statins
Acetylsalicylic acid (aspirin)
Agents used to prevent or treat direct complications of atherosclerosis
Antiplatelet agents
Anticoagulants
Thrombolytics
Table II. Complications following percutaneous coronary intervention.
Complications at the puncture site
Minor superficial bleeding
Major arterial bleeding
Retroperitoneal bleeding
Vessel spasm
Pseudoaneurysm
Infection
Shock – death
Coronary complications
Spasm
Thrombosis and embolism
Dissection – vessel closure
Closure of a side branch
Misplacement or loss of stent
Wire exit – pericardial bleeding, cardiac tamponade
Myocardial infarction
Stent infection
Cardiac arrhythmias
Ventricular extra systoles
Supraventricular extra systoles
Atrial fibrillation / flutter
Ventricular fibrillation / flutter
Bradycardia – vasovagal reactions
Cardiac arrest
Chest pain (ischemia, pericarditis, other causes)
Drug- or contrast allergy
Renal impairment/failure
Stroke
Restenosis at interventional site (< 3 months)
Table III. The most common early complications found in a survey of 720 consecutive patients undergoing coronary revascularization at Landspitali University Hospital between 2002 and 2006.
Variable | n = 720, % | p-value |
Major complications | 118 16) | 0.44 |
Stroke | 16 (2) | 0.79 |
Deep sternal wound infection | 6 (0.8) | 0.84 |
Renal injury requiring dialysis | 12 (2) | 0.97 |
Perioperative myocardial infarction | 95 (13) | 0.35 |
Multi organ failure | 23 (3) | 0.60 |
Sternal insufficience | 19 (3) | 0.31 |
Minor complications | 391 (54) | 0.05 |
Atrial fibrillation/flutter | 294 (41) | 0.50 |
Superficial wound infection | 65 (9) | 0.53 |
Pneumonia | 45 (6) | 0.41 |
Urinary tract infection | 27 (4) | 0.11 |
Figure 1. Stabilization of an unstable atherosclerotic coronary artery plaque with lipid lowering statins. Picture: Guðbjartur Kristófersson.
Figure 2. Coronary angiography showing significant stenosis in the left coronary atery (a) that was dilated and coronary stent implanted (arrow). Picture: Ragnar Danielsen.
Figure 3. Percutaneous coronary intervention with placement of coronary stent.
Figure 4. Schematic drawing of coronary artery bypass grafting (CABG) procedure. The left internal mammary artery (LIMA) has been grafted to the left anterior descending artery (LAD) and two separate greater saphaneous vein grafts have been anastomosed to additional coronary targets. Picture: Hannes Sigurjónsson.
Figure 5 (a). CABG at Landspitali. The heart- and lungmachine is seen in front. Picture: Ragnar Th. Sigurðsson. (b). Specially designed instruments for performing coronary bypass surgery on a beeting heart (off-pump). With courtesy of Medtronic Inc.
Figure 6a-c. Harvest of left internal mammary artery (a), and great saphenous vein (b), and a deep sternal wound infection following CABG. Pictures: Tómas Guðbjartsson.
Figure 7. Overall and disease-specific survival of patients that underwent CABG in Iceland between 2002 and 2006 (Kaplan-Meier). Broken lines indicate 95% confidence interval.